BIIB FY 2020 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena

BIIBBiogen Inc.

$28B

FY 2020 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$13.4B-6.5% YoY

Gross Profit

$11.6B86.6% margin

Operating Income

$4.6B34.2% margin

Net Income

$4.0B29.8% margin

EPS (Diluted)

$24.80

Cash Flow

Operating Cash Flow

$4.2B

Free Cash Flow

$3.8B

Stock-Based Comp.

$198M

Balance Sheet

Total Assets

$24.6B

Total Liabilities

$13.9B

Stockholders' Equity

$10.7B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13.4B	$14.4B	-6.5%
Gross Profit	$11.6B	$12.4B	-6.3%
Operating Income	$4.6B	$7.0B	-34.8%
Net Income	$4.0B	$5.9B	-32.1%